genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • GEN Protocols
  • Resources
    • Summits
    • Webinars
    • GEN Live
    • eBooks/Perspectives
    • Podcasts
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • – INSIDE –
    PRECISION MEDICINE
Search
  • About GEN
  • Contact GEN
  • Subscribe/Update Preferences
  • Log In
Sign in
Welcome! Log into your account
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
    • Autoimmune Disease Drugs

      Amgen to Acquire ChemoCentryx for $3.7B, Bolstering Autoimmune Portfolio

      Novel Coronavirus (2019-nCoV) Corona virus vaccine vial dose flu shot drug needle syringe medical concept vaccination hypodermic injection treatment disease care hospital prevention immunization
      Antibodies

      Monoclonal Antibody Prevents Malaria in Clinical Trial

      Alzheimers

      Novel Alzheimer’s Therapy without Inflammatory Side Effects

      News

      Muscle Regeneration May Be Boosted by Naturally Occurring Compound

      Bacteriophages infecting bacteria, illustration
      Bacteriophage

      Oral Combination Phage Therapy Targets IBD-Related Gut Bacteria, Spares Helpful Microbes

  • Insights
    • AllTrends for 2020Trends for 2021
      Amyloid plaques in Alzheimer's disease
      Alzheimers

      Questionable Data Jeopardizes Alzheimer’s Amyloid Theory

      Cancer

      Left-Field Lessons in Immunity: Z-Nucleic Acids Stage a Comeback

      Woman with lab coat in technical room with a fermenter
      Antibodies

      Biomanufacturing Parallels the Semiconductor Chip Revolution

      Two scientists in conversation, standing in laboratory
      Bioprocessing

      Altering Vector Genetics Improves Cell-free Protein Synthesis

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • NIH Building
      A-Lists

      Top 50 NIH-Funded Institutions of 2022

      Bristol Myers Squibb building
      A-Lists

      Top 10 U.S. Biopharma Clusters

      Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      stocks go up
      A-Lists

      Top 25 Biotech Companies of 2022

      coronavirus
      A-Lists

      Seven Biopharma Trends to Watch in 2022

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • GEN Protocols
  • Resources
    • Summits
    • Webinars
    • GEN Live
    • eBooks/Perspectives
    • Podcasts
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • – INSIDE –
    PRECISION MEDICINE
Home Molecular Diagnostics/In vitro Diagnostics Cancer Testing Page 2

Cancer Testing

  • Cancer Testing
  • Cardiovascular Testing
  • Companion Diagnostics
  • Direct to Consumer Testing
  • Drugs of Abuse Testing
  • Genetic Disease Testing
  • Infectious Disease Diagnostics
  • Inherited Disease Diagnostics
  • Laboratory Developed Tests (LDTs)
  • Noninvasive Diagnostics
  • Point of Care Testing
  • Prenatal/Postnatal Testing
    Latest
    • Latest
    • Featured posts
    • Most popular
    • 7 days popular
    • By review score
    • Random
    Cancer malignant cells
    Cancer Testing

    KRAS Mutations Create Biomarker Signature By Altering RNA “Dark Matter”

    Cancer Testing

    Whole-Exome Sequencing Predicts Response to Cancer Immunotherapy

    MicroRNA bullseye
    Cancer Testing

    RNA Sequencing Improves Gene Fusion Detection in Childhood Cancers

    Liquid Biopsies

    Blood Stake: Roche Raises Freenome Investment to $360M

    Source: Marvin 101/Wikimedia
    Cancer Testing

    Cancer Drug Response and Outcome Predicted from Cell Mass Changes

    A blood-based biopsy called thromoboSeq can screen platelets for cancer-linked RNA. The platelets that contain such RNA are referred to as tumor-educated platelets. [Best et al.
    Cancer Testing

    Liquid Biopsy Reads RNA Collected by Platelets to Diagnose Cancer

    Cancer Testing

    Immunovia Sets Up U.S. Base to Commercialize Biomarker Test for Early...

    Cancer Testing

    Philips, MSK Partner on Genome Analytics for Pancreatic Cancer Precision Medicine

    Cancer Testing

    MDxHealth, GROW Expand Epigenetic Cancer Diagnostics Collaboration

    Cancer Testing

    MDxHealth, Exact Agree to Collaborate on Epigenetics and MDx

    Cancer Testing

    MDxHealth Licenses Cancer Methylation Visualization Platform from Ghent University

    Cancer Testing

    Epigenetic-Chronological Age Mismatch Warns of Cancer

    Cancer Testing

    Pan-Cancer Epigenetic Signature Readable in Circulating Tumor DNA

    Cancer Testing

    Illumina Launches GRAIL, Focused on Blood-Based Cancer Screening

    Cancer Testing

    Tracking Cancer Progression in Real Time Using Circulating DNA

    123Page 2 of 3

    Recently Featured

    Questionable Data Jeopardizes Alzheimer’s Amyloid Theory

    Questionable Data Jeopardizes Alzheimer’s Amyloid Theory

    Amgen to Acquire ChemoCentryx for $3.7B, Bolstering Autoimmune Portfolio

    Amgen to Acquire ChemoCentryx for $3.7B, Bolstering Autoimmune Portfolio

    Novel Alzheimer’s Therapy without Inflammatory Side Effects

    Novel Alzheimer’s Therapy without Inflammatory Side Effects

    Muscle Regeneration May Be Boosted by Naturally Occurring Compound

    Muscle Regeneration May Be Boosted by Naturally Occurring Compound

    Read the Digital Edition

    Explore

    • About GEN
    • Contact GEN
    • GEN Protocols
    • GEN Staff
    • Editorial Guidelines
    • Reprints and Permissions
    • Scientific Advisory Board

    Advertise

    • Media Kit and Planning Calendar
    • Magazine Advertising
    • Website Banner Advertising
    • eNewsletter Advertising
    • Webinar Sponsorship
    • eBook Advertising
    • List Rental
    • Advertising Terms and Conditions

    Resources

    • Get the GEN Magazine
    • Get the GEN Email Newsletter
    • New Products
    • Videos
    • Webinars
    • Podcasts
    • Privacy Policy
    • Inside Precision Medicine
    • Home
    • Terms of Service
    • Privacy Policy
    • Cookie Policy
    • Mary Ann Liebert, Inc.
    Copyright © 2022 Genetic Engineering & Biotechnology News. All Rights Reserved.
    sponsored
    Scroll Up